Prosecution Insights
Last updated: May 29, 2026

Examiner: COLLINS, CYNTHIA E

Tech Center 1600 • Art Units: 1638 1662

This examiner grants 82% of resolved cases

Performance Statistics

82.4%
Allow Rate
+22.4% vs TC avg
1,339
Total Applications
+9.2%
Interview Lift
867
Avg Prosecution Days
Based on 1314 resolved cases, 2023–2026

Rejection Statute Breakdown

1.8%
§101 Eligibility
15.4%
§102 Novelty
22.7%
§103 Obviousness
49.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18536740 WHEAT VARIETY PMWH102204613 Final Rejection BASF SE
18409926 SOYBEAN VARIETY Non-Final OA SYNGENTA CROP PROTECTION AG
18882113 PLANT REGULATORY ELEMENTS AND USES THEREOF Non-Final OA Monsanto Technology LLC
17748857 METHODS AND COMPOSITIONS FOR GENOME EDITING VIA HAPLOID INDUCTION Final Rejection Monsanto Technology LLC
18341340 ALTERATION OF VESICULAR TRAFFICKING IN GENE EDITED WHEAT CELLS AND PLANTS WITH HETEROLOGOUS REGULATORY ELEMENTS THAT INCREASE GENE EXPRESSION Final Rejection INARI AGRICULTURE TECHNOLOGY, INC.
18302601 GENE EDITED SOYBEAN PLANTS WITH ENHANCED TRAITS Final Rejection INARI AGRICULTURE TECHNOLOGY, INC.
18509879 Inbred Broccoli Line BG-3 Final Rejection Sakata Seed Corporation
18476259 METHODS FOR PROMOTING PLANT HEALTH USING FREE ENZYMES AND MICROORGANISMS THAT OVEREXPRESS ENZYMES Non-Final OA Spogen Biotech Inc.
18476270 METHODS FOR PROMOTING PLANT HEALTH USING FREE ENZYMES AND MICROORGANISMS THAT OVEREXPRESS ENZYMES Final Rejection Spogen Biotech Inc.
18302458 METHODS FOR PROMOTING PLANT HEALTH USING FREE ENZYMES AND MICROORGANISMS THAT OVEREXPRESS ENZYMES Final Rejection Spogen Biotech Inc.
18586963 MEDICAL HEMP CULTIVAR PINKPEPPER AND PRIMER SET COMPOSITION FOR IDENTIFYING THE SAME Non-Final OA CHUNCHEON BIOINDUSTRY FOUNDATION
18508863 MODIFIED PLANTS AND METHODS OF DETECTING PATHOGENIC DISEASE Final Rejection INSIGNUM AGTECH, LLC.
17605724 CODON OPTIMIZED SYNTHETIC NUCLEOTIDE SEQUENCES ENCODING CRY2Ai PROTEIN AND USES THEREOF Final Rejection DCM SHRIRAM LIMITED

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month